Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

October 06, 2015 2:51 PM ET


Company Overview of Bio Products Laboratory Ltd

Company Overview

Bio Products Laboratory Ltd is engaged in the research and development, and manufacture of human blood plasma products. It offers normal intravenous immunoglobulin preparations for the treatment of patients who have no or very low levels of antibody production; products for primary and secondary immunodeficiency; idiopathic thrombocytopenic purpurafor; specific immunoglobulins; and products for Kawasaki disease. The company also provides products for Guillain-Barré Syndrome, a short-term inflammation of the nerves that control the arms and legs; Human Albumin that is used for the restoration and maintenance of circulating blood volume; and Factor VIII and Albumin products. It supply its plas...

Dagger Lane

Elstree,  WD6 3BX

United Kingdom

Founded in 1950


44 20 8957 2200


44 20 8957 2601

Key Executives for Bio Products Laboratory Ltd

Chief Executive
Age: 53
Chief Operating Officer
Medical Director
Compensation as of Fiscal Year 2015.

Bio Products Laboratory Ltd Key Developments

Bio Products Laboratory, Limited Announces Enrollment of the First Subject in Phase III Clinical Trial to Evaluate New Subcutaneous Immunoglobulin Product for Patients with Primary Immunodeficiency

Bio Products Laboratory, Limited announced that the first subject has enrolled in SCIG03, a clinical trial evaluating the safety and pharmacokinetics of SubgamVF, 16% liquid immunoglobulin for the treatment of primary immunodeficiency. The trial, titled, 'A Phase III, Multicenter, Open-Label Study to Evaluate the Pharmacokinetics and Safety of SubgamVF in Primary Immunodeficiency Diseases' ( identifier, NCT01884311), will take place in the U.S. and will form the basis of a biologics license application for U.S. marketing authorization. The trial will enroll 35 patients with primary immunodeficiency and treat them for up to 26 weeks. The pharmacokinetics of SubgamVF will be assessed and will be compared to previous studies. Subgam-VF is a 16% immunoglobulin product made from human plasma specifically for subcutaneous use. The product is undergoing testing in the U.S. and has not been evaluated by the U.S. Food and Drug Administration.

Bio Products Laboratory Limited Announces Approval of Gammaplex for Pediatric Patient

Bio Products Laboratory Limited announced the approval of Gammaplex for pediatric patients two years of age and older who have primary humoral immunodeficiencies. The approval was based on data submitted to the U.S. Food and Drug Administration as part of a post-marketing commitment following approval of Gammaplex for replacement therapy in adults in 2009. Primary immunodeficiencies are a constellation of immune disorders that can negatively impact the body’s ability to fight infection. In some primary immunodeficiencies, the immune system does not manufacture adequate quantities of antibodies such as immune globulin G. This indication includes, but is not limited to, the humoral immune defect in common variable immunodeficiency, X linked agammaglobulinemia, congenital agammaglobulinemia, Wiskott Aldrich syndrome, and severe combined immunodeficiencies.

Similar Private Companies By Industry

Company Name Region
AQIX Ltd. Europe
Orla Protein Technologies Ltd Europe
Syntropharma Limited Europe
Emergent Product Development UK Limited Europe
TCS Cellworks Ltd. Europe

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Bio Products Laboratory Ltd, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at